| 发明名称 |
Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 摘要 |
Compositions and methods for islet neogenesis therapy comprising an EGF and a gastrin in combination with immune suppression, and for treating or preventing early stage diabetes with a gastrin/CCK receptor ligand and an immunosuppressant are provided.
|
| 申请公布号 |
US7560425(B2) |
申请公布日期 |
2009.07.14 |
| 申请号 |
US20030517135 |
申请日期 |
2003.06.09 |
| 申请人 |
WARATAH PHARMACEUTICALS INC. |
发明人 |
BRAND STEPHEN J.;CRUZ ANTONIO |
| 分类号 |
A61K38/00;A61K45/06;A01N45/00;A61K31/133;A61K31/135;A61K31/136;A61K31/14;A61K31/343;A61K31/436;A61K31/519;A61K31/52;A61K31/573;A61K31/675;A61K38/18;A61K38/21;A61K38/22;A61K38/28;A61K39/395;A61K48/00;A61P3/10;A61P37/06;A61P43/00 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
